The Association Between C24:0/C16:0 Ceramide Ratio and Cardiorespiratory Fitness is Robust to Effect Modifications by Age and Sex.
Jule ZatloukalStephanie ZyllaMarcello R P MarkusRalf EwertSven GläserHenry VölzkeDiana AlbrechtNele FriedrichMatthias NauckLinda R PetersonXuntian JiangJean E SchafferStephan B FelixMarcus DörrMartin BahlsStefan GrossPublished in: Advanced biology (2024)
Ceramides and cardiorespiratory (CR) fitness are both related to cardiovascular diseases. The associations of three blood plasma ceramides (C16:0, C22:0, and C24:0) with CR fitness in the population-based Study of Health in Pomerania (SHIP-START-1; n = 1,102; mean age 50.3 years, 51.5% women) are investigated. In addition, subgroup analysis according to age (</≥54 years) and sex (female/male) is performed. Ceramides are quantified by liquid chromatography/mass spectrometry (LC/MS). CR fitness is assessed by a cardiopulmonary exercise test. Sex and age independent associations are found for higher levels of C24:0 and C24:0/C16:0 ratio with higher maximal oxygen consumption (VO 2 peak) kg -1 and oxygen consumption at the anaerobic threshold (VO 2 @AT 1 ) as well as for the relation of C24:0/C16:0 with maximum workload (Wattmax kg -1 ). In contrast, age/sex subgroup specific inverse associations with Wattmax kg -1 are found in women <54 years for C22:0, while a positive association in men ≥54 years. Higher levels of C24:0 are associated with higher Wattmax kg -1 , except for women <54 years, where no significant association can be found. The findings suggest that the use of single ceramides as cardiovascular biomarkers may be inferior, compared to ceramide ratio C24:0/C16:0. Therefore C24:0/C16:0 ratio may be a more suitable and robust cardiovascular biomarker and should be preferred over single ceramides.
Keyphrases
- mass spectrometry
- liquid chromatography
- body composition
- physical activity
- polycystic ovary syndrome
- healthcare
- magnetic resonance
- pregnancy outcomes
- randomized controlled trial
- resistance training
- high intensity
- clinical trial
- magnetic resonance imaging
- risk assessment
- high resolution
- high resolution mass spectrometry
- skeletal muscle
- wastewater treatment
- pregnant women
- single molecule
- human health
- study protocol
- open label
- cardiovascular events